Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
US-11096910-B2 · Aug 24, 2021 · US
This page is not indexed by search engines while we improve data quality.
Patent family 56550232
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 56550232 |
| Family type | — |
| Earliest priority | Jul 22, 2015 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US11096910B2 — Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease |
Representative publication
Best representative member for this family based on priority and filing country.
US11096910B2 — Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease (published Aug 24, 2021)
Member publications
Related publications in this family.